A toolmaker's perspective on CRISPR-directed gene editing as a therapeutic strategy for leukemia and beyond

Expert Rev Hematol. 2021 Jul;14(7):587-592. doi: 10.1080/17474086.2021.1935853. Epub 2021 Jun 7.

Authors

Eric B Kmiec¹, Kevin Bloh^{1

2}

Affiliations

¹ Gene Editing Institute, Helen F. Graham Cancer Center and Research Institute, Newark, USA.
² University of Delaware, Department of Medical and Molecular Sciences, College of Health Sciences, Newark, USA.

PMID: 34047246
DOI: 10.1080/17474086.2021.1935853

No abstract available

Keywords: CRISPR; Cancery; Gene Editing; T-Cell Therapy.

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

CRISPR-Cas Systems
Clustered Regularly Interspaced Short Palindromic Repeats
Gene Editing*
Genetic Therapy
Humans
Leukemia* / genetics
Leukemia* / therapy